Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT138902183893N1Phase 4Completed
Phase 4 trial of chlorhexidine in carious lesion, sponsored by Tabriz University of Medical Sciences. Primary endpoint: Stability of modified oral microflora. Started Jul 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT138902183893N1.